Tracleer® (bosentan)
Tracleer® (bosentan) is an oral dual endothelin receptor antagonist. Tracleer® is the only PAH therapy proven to delay disease progression, reduce severity and symptoms. Tracleer is the only oral PAH therapy with an established safety and tolerability profile in more than 80,000 patients worldwide.
US residents only: www.tracleer.com

